- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pharma exports exclusion from RoDTEP scheme will hit competitiveness: Industry bodies
New Delhi: Exclusion of pharma goods from the export promotion scheme RoDTEP will adversely impact the sector's competitiveness, industry bodies said on Thursday.
The government on Tuesday announced rates of tax refunds under the Remission of Duties and Taxes on Exported Products (RoDTEP) scheme for 8,555 products, such as marine goods, yarn and dairy items, to boost exports.
However, three sectors -- steel, chemicals and pharmaceuticals -- were excluded from getting the benefits of RoDTEP.
Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said, "The exclusion of pharma exports from the RoDTEP scheme will adversely impact the pharma sector's competitiveness."
The exclusion deprives pharmaceutical exporters of the level playing field vis-a-vis global manufacturers. This is a highly regulated sector and calls for huge capital investment for setting up manufacturing infrastructure, he added.
"The industry presented the data to the RoDTEP committee for consideration," Jain said.
For sustaining India's export competitiveness, RoDTEP benefits should be extended to the pharmaceutical sector, given its importance in providing access to affordable medicines to patients in India and around the world, he added.
Indian Drug Manufacturers' Association (IDMA) Executive Director Ashok Kumar Madan said consequent to the announcement of the RoDTEP scheme, the pharma industry had been waiting anxiously for the announcement of rates.
During these times of pandemic there has been an overall increase in prices of raw materials, packing materials and overseas freight rates.
"The redemption of the taxes paid could have helped us to sustain and further the exports," he added.
The exclusion will have a severe impact on exports from small and medium enterprises in the sector, Madan said.
Commerce Secretary B V R Subrahmanyam on Tuesday had said that Rs 19,400 crore would be available for 2021-22 for both the RoDTEP and the Rebate of State and Central Taxes and Levies (RoSCTL).
The RoSCTL scheme was announced for the export of garments and apparels.
For the RoDTEP scheme, the amount is Rs 12,454 crore and the remaining Rs 6,946 crore for RoSCTL.
The government had announced the RoDTEP scheme in March 2020. It was to come into effect from January 1 this year. The rates have been finally notified after seven-and-a-half months in August 2021.
Read also: API exports stood at Rs 32,856 crore, imports at Rs 28,529 crore in FY21: Mansukh Mandaviya
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751